Iron chelation in rheumatoid arthritis: clinical and laboratory evaluation.
Open Access
- 1 April 1990
- journal article
- research article
- Published by BMJ in Annals Of The Rheumatic Diseases
- Vol. 49 (4), 268-269
- https://doi.org/10.1136/ard.49.4.268-b
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Ocular toxicity of desferrioxamine--an example of copper promoted auto-oxidative damage?British Journal of Ophthalmology, 1989
- Effect of iron chelation on inflammatory joint disease.Annals Of The Rheumatic Diseases, 1987
- Serum β2-Microglobulin as a Marker of Activity in Systemic Lupus ErythematosusScandinavian Journal of Rheumatology, 1986
- Studies on the differential mechanisms of inhibition of ribonucleotide reductase by specific inhibitors of the non-heme iron subunitAdvances in Enzyme Regulation, 1984
- Lipid peroxidation in rheumatoid arthritis: Thiobarbituric acid-reactive material and catalytic iron salts in synovial fluid from rheumatoid patientsClinical Science, 1984
- THE IMPORTANCE OF IRON IN RHEUMATOID DISEASEThe Lancet, 1981
- Plasma and urinary levels of beta2 microglobulin in rheumatoid arthritis.Annals Of The Rheumatic Diseases, 1978
- Concentration of iron in synovial membrane, synovial fluid, and serum in rheumatoid arthritis and other joint diseases.Annals Of The Rheumatic Diseases, 1968
- Treatment of Rheumatoid Arthritis with Immunosuppressive Drugs: II. Immunological StudyActa Rheumatologica Scandinavica, 1965
- The Biochemistry of Desferrioxamine and its Relation to Iron MetabolismAnnals of the New York Academy of Sciences, 1964